NYSE · ACH
Accendra Health, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ACH: Nov 05, 2026
Accendra Health, Inc. Common Stock is expected to report earnings on 11/05/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.04. The reported EPS for the same quarter last year was $0.25.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.04 | $-0.03 | $-0.06 | 2 |
| Dec 2026 | $0.23 | $0.23 | $0.23 | 1 |
| Mar 2027 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Jun 2027 | $-0.07 | $-0.07 | $-0.07 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Fintel · NASDAQ.com · Zacks · RTTNews- Fintel · Oct 23, 12:10 PM EDTAccendra Health Consensus Price Target Decreased by 16.53% to $1.29The average one-year price target for Accendra Health (NYSE:ACH) (DB:6OM) has been revised to $1.29 / share. This is a decrease of 16.53% from the prior estimate of $1.54 dated September 29, 2026. These figures represent aggregate analyst targets compiled by Fintel and do not con
- NASDAQ.com · Oct 9, 9:30 AM EDTPre-Market Most Active for Oct 9, 2026 : PCG, SPCX, CRGY, NOK, TQQQ, SQQQ, IBIT, VZ, T, NVDA, TSLL, ACHRThe NASDAQ 100 Pre-Market Indicator is down -63.57 to 30,819.58. The total Pre-Market volume is currently 109,467,426 shares traded.The following are the most active stocks for the pre-market session: PG&E Corp (PCG) is +0.05 at $12.72, with 15,802,599 shares traded., follow
- Zacks · Oct 9, 5:12 AM EDTNew Strong Sell Stocks for October 9thACH, ARDX and DPRO have been added to the Zacks Rank #5 (Strong Sell) List on October 9th, 2026.
- Zacks · Oct 6, 2:40 AM EDTNew Strong Sell Stocks for October 6thVLVLY, ACH and CCJ have been added to the Zacks Rank #5 (Strong Sell) List on October 6th, 2026.
- RTTNews · Sep 17, 6:51 AM EDTAccendra Health Names Kenneth Gardner-Smith As New CEO(RTTNews) – Accendra Health, Inc. (ACH), a healthcare company, on Thursday said it named Kenneth Gardner-Smith as its new President and Chief Executive Officer, effective early in the fourth quarter of 2026.
- The Motley Fool · Aug 17, 11:59 AM EDTAccendra Health (ACH) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Aug 10, 10:41 AM EDTAccendra Health Reports Lower Q2 Revenue, Sets 2026 Guidance; Adopts Tax Asset Plan; Stock Down(RTTNews) – Accendra Health, Inc. (ACH) reported financial results for the second quarter ended June 30, 2026, showing a decline in revenue, as the company continues its transition following separation from Owens & Minor.
- Zacks · Aug 6, 7:10 PM EDTICU Medical (ICUI) Tops Q2 Earnings and Revenue EstimatesICU Medical (ICUI) delivered earnings and revenue surprises of +24.08% and +2.33%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jul 2, 9:01 AM EDTIs the Options Market Predicting a Spike in Accendra Health Stock?Investors need to pay close attention to ACH stock based on the movements in the options market lately.
- Zacks · May 28, 8:48 AM EDTAre Options Traders Betting on a Big Move in Accendra Health Stock?Investors need to pay close attention to ACH stock based on the movements in the options market lately.
- Fintel · May 14, 9:12 PM EDTAccendra Health (ACH) Price Target Increased by 28.92% to 4.27The average one-year price target for Accendra Health (NYSE:ACH) has been revised to $4.27 / share. This is an increase of 28.92% from the prior estimate of $3.32 dated April 25, 2026. The price target is an average of many targets provided by analysts. The la
- BNK Invest · May 11, 3:33 PM EDTNotable Monday Option Activity: PDFS, ACH, EOSELooking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in PDF Solutions Inc. (Symbol: PDFS), where a total volume of 5,715 contracts has been traded thus far today, a contract volume which is representative of approxima
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Accendra Health, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.